<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:34:52Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10547361" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10547361</identifier>
        <datestamp>2023-10-04</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jah38753" xml:lang="en" article-type="methods-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10547361</article-id>
              <article-id pub-id-type="pmcid">PMC10547361</article-id>
              <article-id pub-id-type="pmc-uid">10547361</article-id>
              <article-id pub-id-type="pmid">37642035</article-id>
              <article-id pub-id-type="pmid">37642035</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.123.031182</article-id>
              <article-id pub-id-type="publisher-id">JAH38753</article-id>
              <article-id pub-id-type="other">JAHA/2023/031182-T</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Protocols</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Protocols</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Study Design, Rationale, and Methodology for <styled-content style="fixed-case" toggle="no">Promote</styled-content> Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The <styled-content style="fixed-case" toggle="no">PROVE</styled-content> Trial</article-title>
                <alt-title alt-title-type="right-running-head">The <styled-content style="fixed-case" toggle="no">PROVE</styled-content> Clinical Trial</alt-title>
                <alt-title alt-title-type="left-running-head">Whipple et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah38753-cr-0001" contrib-type="author">
                  <name>
                    <surname>Whipple</surname>
                    <given-names>Mary O.</given-names>
                  </name>
                  <degrees>PhD, RN</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7073-3224</contrib-id>
                  <xref rid="jah38753-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0002" contrib-type="author">
                  <name>
                    <surname>Pfammatter</surname>
                    <given-names>Angela Fidler</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0081-4090</contrib-id>
                  <xref rid="jah38753-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0003" contrib-type="author">
                  <name>
                    <surname>Spring</surname>
                    <given-names>Bonnie</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0692-9868</contrib-id>
                  <xref rid="jah38753-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0004" contrib-type="author">
                  <name>
                    <surname>Rejeski</surname>
                    <given-names>W. Jack</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2281-4649</contrib-id>
                  <xref rid="jah38753-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0005" contrib-type="author">
                  <name>
                    <surname>Treat‐Jacobson</surname>
                    <given-names>Diane</given-names>
                  </name>
                  <degrees>PhD, RN</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3296-8764</contrib-id>
                  <xref rid="jah38753-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0006" contrib-type="author">
                  <name>
                    <surname>Domanchuk</surname>
                    <given-names>Kathryn J.</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref rid="jah38753-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0007" contrib-type="author">
                  <name>
                    <surname>Dressler</surname>
                    <given-names>Emily V.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6054-7839</contrib-id>
                  <xref rid="jah38753-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0008" contrib-type="author">
                  <name>
                    <surname>Ferrucci</surname>
                    <given-names>Luigi</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6273-1613</contrib-id>
                  <xref rid="jah38753-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0009" contrib-type="author">
                  <name>
                    <surname>Gildea</surname>
                    <given-names>Lois</given-names>
                  </name>
                  <degrees>BSN, RN</degrees>
                  <xref rid="jah38753-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0010" contrib-type="author">
                  <name>
                    <surname>Guralnik</surname>
                    <given-names>Jack M.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref rid="jah38753-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0011" contrib-type="author">
                  <name>
                    <surname>Harvin</surname>
                    <given-names>Lea</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref rid="jah38753-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0012" contrib-type="author">
                  <name>
                    <surname>Leeuwenburgh</surname>
                    <given-names>Christiaan</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0826-4257</contrib-id>
                  <xref rid="jah38753-aff-0008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0013" contrib-type="author">
                  <name>
                    <surname>Polonsky</surname>
                    <given-names>Tamar S.</given-names>
                  </name>
                  <degrees>MD, MSCI</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2112-9244</contrib-id>
                  <xref rid="jah38753-aff-0009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0014" contrib-type="author">
                  <name>
                    <surname>Reynolds</surname>
                    <given-names>Eric</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref rid="jah38753-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0015" contrib-type="author">
                  <name>
                    <surname>Stowe</surname>
                    <given-names>Cynthia L.</given-names>
                  </name>
                  <degrees>MPM</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1887-3294</contrib-id>
                  <xref rid="jah38753-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0016" contrib-type="author">
                  <name>
                    <surname>Sufit</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8827-2753</contrib-id>
                  <xref rid="jah38753-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0017" contrib-type="author">
                  <name>
                    <surname>Van Horn</surname>
                    <given-names>Linda</given-names>
                  </name>
                  <degrees>PhD, RDN</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1362-5806</contrib-id>
                  <xref rid="jah38753-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0018" contrib-type="author">
                  <name>
                    <surname>Walkup</surname>
                    <given-names>Michael P.</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref rid="jah38753-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0019" contrib-type="author">
                  <name>
                    <surname>Ambrosius</surname>
                    <given-names>Walter T.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="jah38753-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38753-cr-0020" contrib-type="author" corresp="yes">
                  <name>
                    <surname>McDermott</surname>
                    <given-names>Mary M.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3724-7619</contrib-id>
                  <xref rid="jah38753-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <address>
                    <email>mdm608@northwestern.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="jah38753-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">School of Nursing</named-content>
                <institution>University of Minnesota</institution>
                <city>Minneapolis</city>
                <named-content content-type="country-part">MN</named-content>
              </aff>
              <aff id="jah38753-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">College of Education, Health, and Human Sciences</named-content>
                <institution>University of Tennessee</institution>
                <city>Knoxville</city>
                <named-content content-type="country-part">TN</named-content>
              </aff>
              <aff id="jah38753-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Feinberg School of Medicine</named-content>
                <institution>Northwestern University</institution>
                <city>Chicago</city>
                <named-content content-type="country-part">IL</named-content>
              </aff>
              <aff id="jah38753-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Health and Exercise Science</named-content>
                <institution>Wake Forest University</institution>
                <city>Winston‐Salem</city>
                <named-content content-type="country-part">NC</named-content>
              </aff>
              <aff id="jah38753-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Biostatistics and Data Science</named-content>
                <institution>Wake Forest University School of Medicine</institution>
                <city>Winston‐Salem</city>
                <named-content content-type="country-part">NC</named-content>
              </aff>
              <aff id="jah38753-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <institution>National Institute on Aging, National Institutes of Health</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38753-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <institution>University of Maryland School of Medicine</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38753-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <named-content content-type="organisation-division">College of Medicine</named-content>
                <institution>University of Florida</institution>
                <city>Gainesville</city>
                <named-content content-type="country-part">FL</named-content>
              </aff>
              <aff id="jah38753-aff-0009">
                <label>
                  <sup>9</sup>
                </label>
                <institution>University of Chicago Medicine</institution>
                <city>Chicago</city>
                <named-content content-type="country-part">IL</named-content>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>
Correspondence to: Mary M. McDermott, MD, Northwestern University Feinberg School of Medicine, 750 N Lake Shore Dr, 10th Floor, Chicago, IL 60611. Email: <email>mdm608@northwestern.edu</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>29</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>05</day>
                <month>9</month>
                <year>2023</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="500">17</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.v12.17</issue-id>
              <elocation-id>e031182</elocation-id>
              <history>
                <date date-type="received">
                  <day>19</day>
                  <month>6</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>28</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <!--Copyright &#x000a9; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell-->
                <copyright-statement content-type="article-copyright">© 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JAH3-12-e031182.pdf"/>
              <abstract>
                <sec id="jah38753-sec-0001">
                  <title>Background</title>
                  <p>Overweight and obesity are associated with adverse functional outcomes in people with peripheral artery disease (PAD). The effects of weight loss in people with overweight/obesity and PAD are unknown.</p>
                </sec>
                <sec id="jah38753-sec-0002">
                  <title>Methods</title>
                  <p>The PROVE (Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss) Trial is a multicentered randomized clinical trial with the primary aim of testing whether a behavioral intervention designed to help participants with PAD lose weight and walk for exercise improves 6‐minute walk distance at 12‐month follow‐up, compared with walking exercise alone. A total of 212 participants with PAD and body mass index ≥25 kg/m<sup>2</sup> will be randomized. Interventions are delivered using a Group Mediated Cognitive Behavioral intervention model, a smartphone application, and individual telephone coaching. The primary outcome is 12‐month change in 6‐minute walk distance. Secondary outcomes include total minutes of walking exercise/wk at 12‐month follow‐up and 12‐month change in accelerometer‐measured physical activity, the Walking Impairment Questionnaire distance score, and the Patient‐Reported Outcomes Measurement Information System mobility questionnaire. Tertiary outcomes include 12‐month changes in perceived exertional effort at the end of the 6‐minute walk, diet quality, and the Short Physical Performance Battery. Exploratory outcomes include changes in gastrocnemius muscle biopsy measures of mitochondrial cytochrome C oxidase activity, mitochondrial biogenesis, capillary density, and inflammatory markers.</p>
                </sec>
                <sec id="jah38753-sec-0003">
                  <title>Conclusions</title>
                  <p>The PROVE randomized clinical trial will evaluate the effects of exercise with an intervention of coaching and a smartphone application designed to achieve weight loss, compared with exercise alone, on walking performance in people with PAD and overweight/obesity. Results will inform optimal treatment for the growing number of patients with PAD who have overweight/obesity.</p>
                </sec>
                <sec id="jah38753-sec-0004">
                  <title>Registration</title>
                  <p>URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>; Unique identifier: NCT04228978.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah38753-kwd-0001">eating behavior</kwd>
                <kwd id="jah38753-kwd-0002">home‐based exercise</kwd>
                <kwd id="jah38753-kwd-0003">mitochondria</kwd>
                <kwd id="jah38753-kwd-0004">obesity</kwd>
                <kwd id="jah38753-kwd-0005">peripheral artery disease</kwd>
                <kwd id="jah38753-kwd-0006">physical function</kwd>
                <kwd id="jah38753-kwd-0007">randomized controlled trial</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Obesity</kwd>
                <kwd>Exercise</kwd>
                <kwd>Peripheral Vascular Disease</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>National Heart Lung and Blood Institute</funding-source>
                  <award-id>UH3HL141729</award-id>
                  <award-id>U24HL141732</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute on Aging
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000049</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="5"/>
                <page-count count="12"/>
                <word-count count="6786"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>05 September 2023</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.3 mode:remove_FC converted:04.09.2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="jah38753-ntgp-0001">
                <fn id="jah38753-note-0001">
                  <p>This manuscript was sent to Amgad Mentias, MD, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p>
                </fn>
                <fn id="jah38753-note-0002">
                  <p>For Disclosures, see page 11.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jah38753-body-0001">
            <def-list list-content="abbreviations" id="jah38753-lp-0001">
              <title>Nonstandard Abbreviations and Acronyms</title>
              <def-item>
                <term id="jah38753-li-0001">EX</term>
                <def id="jah38753-li-0003">
                  <p>exercise intervention</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38753-li-0004">GOALS</term>
                <def id="jah38753-li-0005">
                  <p>Group‐Oriented Arterial Leg Study</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38753-li-0006">ICC</term>
                <def id="jah38753-li-0008">
                  <p>interclass correlation</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38753-li-0009">LITE</term>
                <def id="jah38753-li-0010">
                  <p>Low Intensity Exercise Intervention in PAD</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38753-li-0011">PROVE</term>
                <def id="jah38753-li-0012">
                  <p>Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38753-li-0013">WL+EX</term>
                <def id="jah38753-li-0014">
                  <p>weight loss plus exercise intervention</p>
                </def>
              </def-item>
            </def-list>
            <p>Lower extremity peripheral artery disease (PAD) affects &gt;230 million adults worldwide,<xref rid="jah38753-bib-0001" ref-type="bibr"><sup>1</sup></xref>, <xref rid="jah38753-bib-0002" ref-type="bibr"><sup>2</sup></xref> and causes significant walking impairment.<xref rid="jah38753-bib-0002" ref-type="bibr"><sup>2</sup></xref> Walking exercise is first‐line therapy to improve walking performance in PAD.<xref rid="jah38753-bib-0003" ref-type="bibr"><sup>3</sup></xref> Individuals with PAD and overweight or obesity have greater functional impairment and faster functional decline than people with PAD and normal weight.<xref rid="jah38753-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="jah38753-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jah38753-bib-0006" ref-type="bibr"><sup>6</sup></xref> Rates of obesity are increasing nationally<xref rid="jah38753-bib-0007" ref-type="bibr"><sup>7</sup></xref> and ≈65% of people with PAD have overweight or obesity.<xref rid="jah38753-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="jah38753-bib-0009" ref-type="bibr"><sup>9</sup></xref> In animals, obesity was associated with impaired limb perfusion<xref rid="jah38753-bib-0010" ref-type="bibr"><sup>10</sup></xref> and in humans, obesity was associated with reduced skeletal muscle mitochondrial biogenesis and activity.<xref rid="jah38753-bib-0011" ref-type="bibr"><sup>11</sup></xref> However, the effects of intentional weight loss in people with PAD who have overweight or obesity are unknown. A combined weight loss and exercise intervention may improve walking performance if weight loss improves adherence to exercise activity by making walking exercise easier, increasing calf perfusion, and improving calf mitochondrial activity and inflammation. However, weight loss may not be beneficial if weight loss exacerbates PAD‐related sarcopenia or if the requirements of the weight loss program interfere with adherence to walking exercise.<xref rid="jah38753-bib-0012" ref-type="bibr"><sup>12</sup></xref>
</p>
            <p>The PROVE (Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss) Trial was designed to compare an intervention intended to achieve weight loss combined with walking exercise to a walking exercise intervention alone. The weight loss intervention and the walking exercise intervention incorporated behavioral change methods. The primary outcome is change in 6‐minute walk distance at 12‐month follow‐up. This article describes the design and methods for the PROVE Trial.</p>
            <sec sec-type="methods" id="jah38753-sec-0006">
              <title>Methods</title>
              <p>The PROVE Trial was reviewed and approved by a single Institutional Review Board through Northwestern University. All participants provide written informed consent. This clinical trial is single‐blind, multicentered, and conducted at Northwestern University (Chicago, IL), the University of Minnesota (Minneapolis, MN), and Tulane University (New Orleans, LA), with the Data Coordinating Center at Wake Forest University School of Medicine (Winston‐Salem, NC). After trial completion, anonymized data and materials will be made publicly available at BioLINCC.</p>
              <sec id="jah38753-sec-0007">
                <title>Participant Identification</title>
                <p>Patients with established PAD or vascular laboratory testing consistent with PAD are contacted via mailed letters, messaging through patient portals, and referrals from vascular specialists. Brochures, flyers, or posters are displayed in relevant clinics. Postcards advertising the study are mailed to people aged 50 years and older in the communities where the trial is conducted. Advertisements on buses and trains in Chicago, Minneapolis, and New Orleans are used to advertise the clinical trial. Field center investigators also identify potential participants from lists of people with PAD who participated in previous studies and expressed interest in future research. Initial eligibility screening occurs by telephone (Table <xref rid="jah38753-tbl-0001" ref-type="table">1</xref>).</p>
                <table-wrap position="float" id="jah38753-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Initial Telephone Screening Questions</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 1: Demographics</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0001">
                            <list-item id="jah38753-li-2013">
                              <label>1.</label>
                              <p>(After a brief study description) Are you interested in hearing more about the study?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0002">
                            <list-item id="jah38753-li-3014">
                              <label>2.</label>
                              <p>How did you hear about the study?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0003">
                            <list-item id="jah38753-li-0015">
                              <label>3.</label>
                              <p>May I ask your biological sex?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0004">
                            <list-item id="jah38753-li-0016">
                              <label>4.</label>
                              <p>What is your age?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0005">
                            <list-item id="jah38753-li-0017">
                              <label>5.</label>
                              <p>What is your date of birth?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 2: PAD</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0006">
                            <list-item id="jah38753-li-0018">
                              <label>6.</label>
                              <p>Has a doctor ever told you that you have blockages in your leg arteries, intermittent claudication, or peripheral artery disease?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0007">
                            <list-item id="jah38753-li-0019">
                              <label>7.</label>
                              <p>Do you get pain, discomfort, tightness, weakness, or other symptoms in your legs when you walk?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0008">
                            <list-item id="jah38753-li-0020">
                              <label>8.</label>
                              <p>Are you a current or former smoker?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0009">
                            <list-item id="jah38753-li-0021">
                              <label>9.</label>
                              <p>Has a doctor ever told you that you had diabetes?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0010">
                            <list-item id="jah38753-li-0022">
                              <label>10.</label>
                              <p>Would you like to be contacted in the future about new research studies?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 3: Interest</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0011">
                            <list-item id="jah38753-li-0023">
                              <label>11.</label>
                              <p>(After a detailed study description) Do you think you are interested in participating?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 4: Inclusion/exclusion</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0012">
                            <list-item id="jah38753-li-0024">
                              <label>12.</label>
                              <p>What is your height?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0013">
                            <list-item id="jah38753-li-0025">
                              <label>13.</label>
                              <p>What is your weight?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0014">
                            <list-item id="jah38753-li-0026">
                              <label>14.</label>
                              <p>For this study, you will be asked to attend 2–3 baseline visits and engage in an intervention for 1 year. During the year you will be asked to attend weekly visits for the first 4 months. These weekly visits will transition to every other week for the 5th and 6th months of the study, and finally, to once‐a‐month sessions for the last 6 months of the study. Will you be able to come to (visit location) for this schedule of visits?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 5: Physical activity</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0015">
                            <list-item id="jah38753-li-0027">
                              <label>15.</label>
                              <p>Do you walk for exercise currently?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If yes, on average, how many days per week do you walk for exercise?</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If yes, on average, how many minutes per day do you walk for exercise?</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 6: Equipment</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0016">
                            <list-item id="jah38753-li-0028">
                              <label>16.</label>
                              <p>Do you have a smartphone?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If no, are you willing to learn how to use a smartphone to record your diet if one is provided to you during the study?</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If yes, please provide the type of device and operating system or version.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 7: Alcohol use</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0017">
                            <list-item id="jah38753-li-0029">
                              <label>17.</label>
                              <p>Do you drink alcohol?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If yes, how many drinks do you have a week?</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 8: Self‐report inclusion/exclusion criteria</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0018">
                            <list-item id="jah38753-li-0030">
                              <label>18.</label>
                              <p>In the last 3 months, have you had a heart attack?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0019">
                            <list-item id="jah38753-li-0031">
                              <label>19.</label>
                              <p>In the last 3 months, have you had a stroke?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0020">
                            <list-item id="jah38753-li-0032">
                              <label>20.</label>
                              <p>Have you had any major surgeries or revascularizations of the heart or legs (ie, procedure to improve blood flow) in the past 3 months?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0021">
                            <list-item id="jah38753-li-0033">
                              <label>21.</label>
                              <p>Do you anticipate any major surgeries or revascularizations (ie, procedure to improve blood flow in the heart or legs) in the next 12 months?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0022">
                            <list-item id="jah38753-li-0034">
                              <label>22.</label>
                              <p>Do you use an oxygen tank other than at night?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0023">
                            <list-item id="jah38753-li-0035">
                              <label>23.</label>
                              <p>Do you have a kidney disease that requires dialysis?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0024">
                            <list-item id="jah38753-li-0036">
                              <label>24.</label>
                              <p>Do you have a foot ulcer or open wound on the bottom of your foot that interferes with walking?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0025">
                            <list-item id="jah38753-li-0037">
                              <label>25.</label>
                              <p>Have you had a significant eating disorder within the past 5 years?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0026">
                            <list-item id="jah38753-li-0038">
                              <label>26.</label>
                              <p>In the last 6 months, have you been treated for schizophrenia or psychosis?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0027">
                            <list-item id="jah38753-li-0039">
                              <label>27.</label>
                              <p>In the last 6 months, have you been hospitalized for a psychiatric disorder?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0028">
                            <list-item id="jah38753-li-0040">
                              <label>28.</label>
                              <p>Do you have Parkinson disease?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0029">
                            <list-item id="jah38753-li-0041">
                              <label>29.</label>
                              <p>Do you have a leg amputation?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0030">
                            <list-item id="jah38753-li-0042">
                              <label>30.</label>
                              <p>Do you use a walker or wheelchair?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0031">
                            <list-item id="jah38753-li-0043">
                              <label>31.</label>
                              <p>Do you have visual impairment that interferes with walking?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0032">
                            <list-item id="jah38753-li-0044">
                              <label>32.</label>
                              <p>In the past 6 months, have you been treated for drug abuse?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0033">
                            <list-item id="jah38753-li-0045">
                              <label>33.</label>
                              <p>In the past 6 months, have you undergone weight loss treatment, or are you currently undergoing weight loss treatment?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0034">
                            <list-item id="jah38753-li-0046">
                              <label>34.</label>
                              <p>Have you gained or lost any weight in the past 6 months?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If yes, how many pounds?</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Section 9: Additional information</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0035">
                            <list-item id="jah38753-li-0047">
                              <label>35.</label>
                              <p>Do you have cancer that has required treatment in the last 2 years?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0036">
                            <list-item id="jah38753-li-0048">
                              <label>36.</label>
                              <p>Do you have foot pain at night that gets better when you sit up and dangle your feet?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If yes, has the foot pain gotten worse in the past month?</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0037">
                            <list-item id="jah38753-li-0049">
                              <label>37.</label>
                              <p>Do you have an implantable cardioverter‐defibrillator?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0038">
                            <list-item id="jah38753-li-0050">
                              <label>38.</label>
                              <p>Are you currently participating in a supervised treadmill exercise or cardiac rehabilitation program, or have you participated in a supervised treadmill exercise or cardiac rehabilitation program in the past 3 months?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0039">
                            <list-item id="jah38753-li-0051">
                              <label>39.</label>
                              <p>Are you currently participating in any other clinical research studies, or have you completed a clinical research study in the last 3 months?</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                </table-wrap>
              </sec>
              <sec id="jah38753-sec-0008">
                <title>Inclusion and Exclusion Criteria</title>
                <p>Inclusion and exclusion criteria are intended to maximize both eligibility and generalizability of the randomized sample (Table <xref rid="jah38753-tbl-0002" ref-type="table">2</xref>). Eligible participants are people with PAD who have either overweight or obesity. Participants with overweight (ie, body mass index [BMI] 25–29.9 kg/m<sup>2</sup>) were included for the following reasons. First, prior work showed that among people with PAD, annual declines in 6‐minute walk distance increased across BMI categories of normal BMI, overweight, and obesity.<xref rid="jah38753-bib-0004" ref-type="bibr"><sup>4</sup></xref> Second, prior work showed a trend across BMI categories of normal BMI, overweight, and obesity with regard to the degree of fatty infiltration of calf skeletal muscle in people with PAD.<xref rid="jah38753-bib-0006" ref-type="bibr"><sup>6</sup></xref> Third, including participants with either overweight or obesity increases generalizability of the results. Fourth, including participants who are overweight was expected to assist with recruitment. Patients who report treatment for overweight or obesity in the past 6 months are excluded (Table <xref rid="jah38753-tbl-0002" ref-type="table">2</xref>). However, patients taking drugs associated with mild‐to‐modest weight loss such as metformin or glucagon‐like peptide receptor agonists to treat diabetes who report no recent treatment for weight loss are not excluded. Data on medication use at baseline and follow‐up is recorded by investigators.</p>
                <table-wrap position="float" id="jah38753-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Inclusion and Exclusion Criteria</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Inclusion criteria</th>
                        <th align="left" rowspan="1" colspan="1">Rationale</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0040">
                            <list-item id="jah38753-li-0052">
                              <label>‐</label>
                              <p>Presence of PAD, defined by:
<list list-type="simple" id="jah38753-list-0041"><list-item id="jah38753-li-0053"><label>○</label><p>ABI ≤0.90 or TBI ≤0.70 at baseline visit</p></list-item><list-item id="jah38753-li-0054"><label>○</label><p>ABI &gt;0.90 and ≤1.00 with a 20% or greater drop in ABI in either leg after the heel‐rise test at baseline visit</p></list-item><list-item id="jah38753-li-0055"><label>○</label><p>ABI &gt;0.90 at baseline visit with vascular laboratory evidence or angiographic evidence of PAD, including: 
<list list-type="simple" id="jah38753-list-0042"><list-item id="jah38753-li-0056"><label>■</label><p>TBI ≤0.70</p></list-item><list-item id="jah38753-li-0057"><label>■</label><p>Duplex ultrasound or angiographic evidence of ≥70% stenosis in lower extremity artery</p></list-item><list-item id="jah38753-li-0058"><label>■</label><p>Post heel‐rise or post‐exercise ABI drop in either leg of ≥20%</p></list-item><list-item id="jah38753-li-0059"><label>■</label><p>ABI ≤0.90</p></list-item></list>
</p></list-item><list-item id="jah38753-li-0060"><label>○</label><p>Individuals with a history of lower extremity revascularization who do not meet the criteria above and have an ABI &gt;0.90 with ≥20% drop in ABI after an exercise test will be eligible if they have symptomatic PAD<xref rid="jah38753-note-0004" ref-type="table-fn">*</xref>
</p></list-item></list>
</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>Accepted criteria for PAD in clinical practice guidelines.<xref rid="jah38753-bib-0003" ref-type="bibr"><sup>3</sup></xref>
</p>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0043">
                            <list-item id="jah38753-li-0061">
                              <label>‐</label>
                              <p>BMI ≥25 kg/m<sup>2</sup>
</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Overweight and obesity are defined as a BMI of 25–29 kg/m<sup>2</sup> and &gt;30 kg/m<sup>2</sup>. Observational evidence demonstrated a linear trend in association of normal BMI, overweight, and obesity with the magnitude of annual decline in 6‐minute walk distance among people with PAD.<xref rid="jah38753-bib-0004" ref-type="bibr"><sup>4</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0044">
                            <list-item id="jah38753-li-0062">
                              <label>‐</label>
                              <p>Age ≥18 years</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">PAD is rare in children</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Exclusion criteria</td>
                        <td align="left" rowspan="1" colspan="1">Rationale</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0045">
                            <list-item id="jah38753-li-0063">
                              <label>‐</label>
                              <p>Above or below knee amputation, critical limb ischemia, or wheelchair confinement.</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">These criteria characterize severe or end stage PAD. Most individuals with PAD do not have severe/end stage PAD.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0046">
                            <list-item id="jah38753-li-0064">
                              <label>‐</label>
                              <p>Walking is limited by a condition other than PAD.</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">The WL+EX intervention is designed to improve walking impairment caused by PAD.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0047">
                            <list-item id="jah38753-li-0065">
                              <label>‐</label>
                              <p>Failure to complete the study run‐in defined as not entering at least 800 kcal of consumed calories per day for at least 5 days during the 7‐day run‐in<xref rid="jah38753-note-0005" ref-type="table-fn"><sup>†</sup></xref>
</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>These individuals may not adhere to study</p>
                          <p>requirements.</p>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0048">
                            <list-item id="jah38753-li-0066">
                              <label>‐</label>
                              <p>Major surgery, coronary or leg revascularization in the past 3 months or anticipated in the next year.</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>These procedures may influence functional performance, independent of study interventions.</p>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0049">
                            <list-item id="jah38753-li-0067">
                              <label>‐</label>
                              <p>Experienced a heart attack or stroke in the past 3 months.</p>
                            </list-item>
                            <list-item id="jah38753-li-0068">
                              <label>‐</label>
                              <p>Major medical illness including lung disease requiring oxygen, Parkinson disease, a life‐threatening illness with life expectancy &lt;6 months, or cancer requiring treatment in the previous 2 years.<xref rid="jah38753-note-0006" ref-type="table-fn"><sup>‡</sup></xref>
</p>
                            </list-item>
                            <list-item id="jah38753-li-0069">
                              <label>‐</label>
                              <p>Increase in angina or angina at rest. Potential participants may become eligible following an abnormal baseline treadmill stress test if they have evidence of an absence of coronary ischemia based on testing with their own physician.</p>
                            </list-item>
                            <list-item id="jah38753-li-0070">
                              <label>‐</label>
                              <p>Current ulcer on bottom of foot</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">These conditions may interfere with the ability to fully participate in and complete the study.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0050">
                            <list-item id="jah38753-li-0071">
                              <label>‐</label>
                              <p>Mini‐Mental Status Examination score &lt;23, dementia, and substance abuse.</p>
                            </list-item>
                            <list-item id="jah38753-li-0072">
                              <label>‐</label>
                              <p>History of being treated for new onset or an acute episode of schizophrenia or psychosis in the past 6 months.</p>
                            </list-item>
                            <list-item id="jah38753-li-0073">
                              <label>‐</label>
                              <p>Hospitalization for a psychiatric disorder in the past 6 months.</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">May interfere with ability to fully adhere to the study intervention or accurately complete questionnaires.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0051">
                            <list-item id="jah38753-li-0074">
                              <label>‐</label>
                              <p>BMI &gt;45 kg/m<sup>2</sup>
</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">These individuals have morbid obesity that requires more intensive treatment than our intervention provides.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0052">
                            <list-item id="jah38753-li-0075">
                              <label>‐</label>
                              <p>History of a significant eating disorder that has been active within the past 5 years or weight loss treatment in the past 6 months. Weight loss treatment includes Weight Watchers, any history of weight loss surgery, and using weight loss medications now or in the past 6 months.</p>
                            </list-item>
                            <list-item id="jah38753-li-0076">
                              <label>‐</label>
                              <p>Weight gain or loss of &gt;25 pounds in the past 6 months</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">The WL+EX intervention is not intended for individuals with an eating disorder. Patients with recent weight loss may have weight change independently of the study interventions.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0053">
                            <list-item id="jah38753-li-0077">
                              <label>‐</label>
                              <p>Unwilling/unable to use a smartphone and unwilling to attend weekly study sessions.</p>
                            </list-item>
                            <list-item id="jah38753-li-0078">
                              <label>‐</label>
                              <p>Non‐English‐speaking</p>
                            </list-item>
                            <list-item id="jah38753-li-0079">
                              <label>‐</label>
                              <p>Visual impairment that limits walking ability</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">These individuals will not be able to fully engage in the intervention.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0054">
                            <list-item id="jah38753-li-0080">
                              <label>‐</label>
                              <p>Excessive alcohol use, defined as &gt;14 drinks/wk in men and &gt;10 alcoholic drinks/wk in women.</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">These individuals may not be able to lose weight.</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="jah38753-list-0055">
                            <list-item id="jah38753-li-0081">
                              <label>‐</label>
                              <p>Currently walking regularly for exercise at a level comparable to the amount of exercise prescribed in the intervention</p>
                            </list-item>
                            <list-item id="jah38753-li-0082">
                              <label>‐</label>
                              <p>Current participation in supervised treadmill exercise, participation in supervised treadmill exercise in the past 3 months or planning to participate in supervised treadmill exercise in the next year.</p>
                            </list-item>
                            <list-item id="jah38753-li-0083">
                              <label>‐</label>
                              <p>Participation in or completion of a clinical trial in the previous 3 months<xref rid="jah38753-note-0007" ref-type="table-fn"><sup>§</sup></xref>
</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">These programs may influence functional performance, independent of study interventions.</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38753-ntgp-0002">
                    <fn id="jah38753-note-0003">
                      <p>ABI indicates ankle brachial index; BMI, body mass index; PAD, peripheral artery disease; TBI, toe brachial index; and WL+EX, weight loss plus exercise.</p>
                    </fn>
                    <fn id="jah38753-note-0004">
                      <label>*</label>
                      <p>Symptomatic PAD will be defined as leg symptoms associated with exertion that resolved within 10 minutes of rest. The presence of symptomatic PAD will be determined based on the claudication questionnaire, the 6‐minute walk, or principal investigator interview/discussion with the potential participant.</p>
                    </fn>
                    <fn id="jah38753-note-0005">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>The run‐in period can be extended to assist participants with learning the app, but participants must demonstrate ability to enter at least 800 kcal per day for at least 5 days of the run‐in period.</p>
                    </fn>
                    <fn id="jah38753-note-0006">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p>Potential participants may still qualify if they have had treatment for an early‐stage cancer in the past 2 years and the prognosis is excellent.</p>
                    </fn>
                    <fn id="jah38753-note-0007">
                      <label>
                        <sup>§</sup>
                      </label>
                      <p>After completing a stem cell or gene therapy intervention, participants will become eligible after the final study follow‐up visit of the stem cell or gene therapy study so long as at least 6 months have passed since the final intervention administration. After completing a supplement or drug therapy (other than stem cell or gene therapy), participants will be eligible after the final study follow‐up visit provided at least 3 months have passed since the final intervention of the trial.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The ankle brachial index (ABI) is performed after 5 minutes of supine rest. The systolic blood pressure is measured twice in the right brachial, dorsalis pedis, posterior tibial, and left dorsalis pedis, posterior tibial, and brachial arteries using a hand‐held Doppler probe. The ABI is calculated for each leg by dividing the mean of the dorsalis pedis and posterior tibial pressures by the mean of the 4 brachial pressures. Participants with a borderline ABI (ie, &gt;0.90 and ≤1.00) may undergo a heel‐rise ABI. The heel‐rise test consists of the participant performing 50 heel rises at a rate of 1 per second and then immediately repeating the ABI.<xref rid="jah38753-bib-0013" ref-type="bibr"><sup>13</sup></xref> Participants with ≥20% drop in the ABI in either leg are eligible. Additional methods of confirming the presence of PAD through angiographic evidence or vascular laboratory testing are summarized in Table <xref rid="jah38753-tbl-0002" ref-type="table">2</xref>.</p>
                <p>Information regarding medical history and demographic characteristics are obtained by questionnaires administered by research staff.</p>
              </sec>
              <sec id="jah38753-sec-0009">
                <title>Run‐In Period</title>
                <p>Before randomization, potential participants are asked to complete a run‐in period for up to 14 days. During the run‐in, participants receive the study application (app) on a smartphone and are asked to enter all food consumed into the app. A smartphone with data plan is provided to participants who do not have their own. Successful completion of the run‐in is defined as entering &gt;800 kcal for at least 5 days. Individuals who do not meet this criterion are not eligible. This helps ensure that randomized participants are willing and able to use the study app regularly.</p>
              </sec>
              <sec id="jah38753-sec-0010">
                <title>Randomization</title>
                <p>Participants unwilling to adhere to the intervention and follow‐up testing, regardless of group assignment, are not randomized. To ensure equipoise, participants are informed of the purpose of the trial and advised that if they are randomized to the exercise group, they should not make changes to their diet, unless advised otherwise by their physician. Potential participants unwilling to continue approximately their same (current) diet if randomized to exercise alone are excluded. Data on participants excluded due to inability to complete run‐in or unwillingness to adhere to the assigned diet and exercise intervention are recorded. For randomization, investigators use permuted block randomization with random block sizes, stratified by site.</p>
              </sec>
              <sec id="jah38753-sec-0011">
                <title>Interventions</title>
                <p>The study interventions combine connective mobile technology with a Group Mediated Cognitive Behavioral intervention and remote coaching. The Group Mediated Cognitive Behavioral intervention uses psychological empowerment, social support, and supportive accountability to increase self‐efficacy and subjective well‐being to facilitate positive behavioral change in older adults. The intervention for each study group is divided into 3 phases: intensive (months 1–4), transition (months 5–6), and maintenance (months 7–12) (Table <xref rid="jah38753-tbl-0003" ref-type="table">3</xref>). During the intensive phase, participants meet weekly in a video conference (Zoom) with other participants in their group and the study coach. Group meetings occur twice per month during the transition phase and once per month during the maintenance phase. All participants receive a manual, a custom smartphone app that is specific to their group assignment, and an ActiGraph accelerometer. Participants randomized to exercise alone receive an app that only tracks exercise but does not track calorie or fat consumption or weight loss. In both groups, participants receive individual coaching calls during the weeks without a group session (Table <xref rid="jah38753-tbl-0004" ref-type="table">4</xref>).</p>
                <table-wrap position="float" id="jah38753-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>Intervention Summary and Frequency of Contact</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="left" rowspan="1" colspan="1">Intensive (mo 1–4)</th>
                        <th align="left" rowspan="1" colspan="1">Transition (mo 5–6)</th>
                        <th align="left" rowspan="1" colspan="1">Maintenance (mo 7–12)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">GMCB sessions</td>
                        <td align="left" rowspan="1" colspan="1">Weekly</td>
                        <td align="left" rowspan="1" colspan="1">Every other wk</td>
                        <td align="left" rowspan="1" colspan="1">1 per mo</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Coach telephone calls</td>
                        <td align="left" rowspan="1" colspan="1">None</td>
                        <td align="left" rowspan="1" colspan="1">Every other wk</td>
                        <td align="left" rowspan="1" colspan="1">3 per mo</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Coach remote monitoring</td>
                        <td align="left" rowspan="1" colspan="1">Weekly</td>
                        <td align="left" rowspan="1" colspan="1">Weekly</td>
                        <td align="left" rowspan="1" colspan="1">Weekly</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Walking exercise recorded using ActiGraph</td>
                        <td align="left" rowspan="1" colspan="1">5 d per wk</td>
                        <td align="left" rowspan="1" colspan="1">5 d/wk</td>
                        <td align="left" rowspan="1" colspan="1">5 d/wk</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Weight loss goal (WL+EX only)</td>
                        <td align="left" rowspan="1" colspan="1">≥0.50 pounds/wk</td>
                        <td align="left" rowspan="1" colspan="1">≥0.50 pounds/wk</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">PROVE study app to record dietary intake (WL+EX only)</td>
                        <td align="left" rowspan="1" colspan="1">Daily</td>
                        <td align="left" rowspan="1" colspan="1">Daily</td>
                        <td align="left" rowspan="1" colspan="1">Daily</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Weight recorded using digital scale (WL+EX)</td>
                        <td align="left" rowspan="1" colspan="1">Daily</td>
                        <td align="left" rowspan="1" colspan="1">Daily</td>
                        <td align="left" rowspan="1" colspan="1">Daily</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38753-ntgp-0003">
                    <fn id="jah38753-note-0008">
                      <p>GCMB indicates group‐mediated cognitive behavioral; EX, exercise; WL+EX, weight loss plus exercise; and PROVE, Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap position="float" id="jah38753-tbl-0004" content-type="Table">
                  <label>Table 4</label>
                  <caption>
                    <p>Items Used to Monitor Fidelity to the Study Intervention</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="left" rowspan="1" colspan="1">WL+EX</th>
                        <th align="left" rowspan="1" colspan="1">EX</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">Coaching skills</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Expresses empathy and asks permission</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Uses active and reflective listening to generate the most appropriate responses and questions</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Supports self‐efficacy</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Elicits change talk</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Uses nonjudgmental curiosity and uses open‐ended questions</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">Treatment fidelity</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Discusses adherence to weighing and self‐monitoring</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">…</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Discusses walking exercise goals</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Discusses calorie goals</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">…</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Discusses the fat gram goal</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">…</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Discusses my action plan</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                        <td align="left" rowspan="1" colspan="1">X</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38753-ntgp-0004">
                    <fn id="jah38753-note-0009">
                      <p>EX indicates exercise; and WL+EX, weight loss plus exercise.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <sec id="jah38753-sec-0012">
                  <title>Exercise Intervention</title>
                  <p>The exercise (EX) component in each group is identical and modeled after the GOALS (Group‐Oriented Arterial Leg Study) and LITE (Low Intensity Exercise Intervention in PAD) home‐based exercise interventions.<xref rid="jah38753-bib-0014" ref-type="bibr"><sup>14</sup></xref>, <xref rid="jah38753-bib-0015" ref-type="bibr"><sup>15</sup></xref> GOALS used a group‐mediated cognitive behavioral framework to help participants with PAD adhere to a home‐based walking exercise program and improved 6‐minute walk distance, compared with the control group.<xref rid="jah38753-bib-0016" ref-type="bibr"><sup>16</sup></xref> Participants are asked to walk for exercise 5 days/wk, beginning with 10 to 15 minutes of walking exercise/session and working up to 40 to 50 minutes/session. Exercise is tracked in the study app. Exercise goals are individualized and intended to increase walking duration by 5 minutes per session each week to facilitate progress toward the goal of 40 to 50 minutes of walking exercise per session.</p>
                  <p>Participants are instructed to walk for exercise at a pace that elicits moderate to severe ischemic leg symptoms.<xref rid="jah38753-bib-0015" ref-type="bibr"><sup>15</sup></xref> Walking duration and intensity are monitored using an ActiGraph accelerometer. Before the start of the intervention, participants are instructed to wear the ActiGraph while walking for exercise for 5 minutes at a pace eliciting moderate‐to‐severe discomfort defined as attaining ischemic leg discomfort of 4 to 5 on a 1 to 5 scale, where 5 is the most severe ischemic leg symptoms. The ActiGraph‐measured intensity (activity counts) during this walking activity is the desired intensity during walking exercise activity. The ActiGraph‐measured walking exercise intensity corresponding to ischemic leg discomfort of 4 to 5 on the 1 to 5 scale is remeasured at scheduled intervals, every 3 months, for each participant and after hospitalizations or major illness.</p>
                  <p>Participants wear the ActiGraph during walking exercise and data are uploaded to CentrePoint. Walking progress is displayed on the study app to the participant (Figure <xref rid="jah38753-fig-0001" ref-type="fig">1</xref>) and on the study website to the coach. The coach and participant use the data to monitor exercise intensity, frequency, and minutes of exercise per session.</p>
                  <fig position="float" fig-type="Figure" id="jah38753-fig-0001">
                    <label>Figure 1</label>
                    <caption>
                      <title>Screenshot of PROVE Trial app showing progress toward walking exercise goal for a participant in the exercise (EX) group.</title>
                      <p>PROVE indicates Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss.</p>
                    </caption>
                    <graphic xlink:href="JAH3-12-e031182-g001" position="anchor" id="jats-graphic-1"/>
                  </fig>
                  <p>During each group Zoom session, the coach presents a topic of the week, such as “overcoming negative thoughts,” “goal setting and self‐monitoring,” or “walking exercise in cold weather.” The coach leads group discussions that facilitate participants sharing their experiences in the walking exercise program, including successes and challenges. At the end of each session, each participant selects their individual walking exercise goals for the next week.</p>
                </sec>
                <sec id="jah38753-sec-0013">
                  <title>Weight Loss Plus Exercise Intervention</title>
                  <p>The exercise component of the weight loss plus exercise (WL+EX) intervention is the same as that described for the EX intervention above.</p>
                  <p>Participants randomized to WL+EX receive a digital scale and a version of the app that enables participants to track their daily dietary intake (Figure <xref rid="jah38753-fig-0002" ref-type="fig">2A</xref>) and weight, in addition to walking exercise. The app provides immediate feedback to participants regarding their adherence to self‐selected goals related to daily intake of kilocalories, total grams of fat and protein, body weight, and walking exercise (Figure <xref rid="jah38753-fig-0002" ref-type="fig">2B</xref>). The PROVE Trial app has been successfully used previously to achieve weight loss in adults with overweight and obesity who did not have PAD.<xref rid="jah38753-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jah38753-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jah38753-bib-0019" ref-type="bibr"><sup>19</sup></xref>
</p>
                  <fig position="float" fig-type="Figure" id="jah38753-fig-0002">
                    <label>Figure 2</label>
                    <caption>
                      <title>Screenshots of progress toward walking exercise and dietary intake goals in the PROVE Trial app for a participant in the weight loss plus exercise (WL+EX) group.</title>
                      <p><bold>A</bold>, Shows examples of food entered in the app and progress toward dietary goals. <bold>B</bold>, Shows progress toward exercise goals. PROVE indicates Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss.</p>
                    </caption>
                    <graphic xlink:href="JAH3-12-e031182-g002" position="anchor" id="jats-graphic-3"/>
                  </fig>
                  <p>The weight loss component of the WL+EX intervention is designed to reduce calorie intake to achieve ≈0.3 kg/wk of weight loss for months 1 to 6 and maintain weight loss during months 7 to 12, with the goal of attaining weight loss of 7% to 10% at 12‐month follow‐up, compared with baseline. An individualized reduced‐kilocalorie goal is determined for each participant according to baseline weight. Participants are encouraged to consume ≈15% to 20% of kilocalories from protein and &lt;7% of kilocalories from saturated fat. These 2 dietary components are monitored using the PROVE Trial app and coach dashboard. Participants are coached on increasing dietary protein‐rich foods if self‐selected intake is inadequate.</p>
                </sec>
                <sec id="jah38753-sec-0014">
                  <title>Monitoring Intervention Adherence</title>
                  <p>Throughout the intervention, coaches remotely monitor each participant's progress at least once/wk using the coaching dashboard that displays walking exercise relative to goals for all participants. For those assigned to WL+EX, the dashboard also displays weight, nutrient, and calorie consumption relative to goals (Figure <xref rid="jah38753-fig-0002" ref-type="fig">2A</xref>). This information is used to provide individualized feedback during individual coaching calls.</p>
                  <p>For all participants, the coach contacts participants outside of their normally scheduled calls for the following: (1) the participant is not recording any exercise minutes for &gt;4 days; (2) exercise minutes in 1 week are &gt;50% less than the participant's walking exercise goal; (3) the participant has difficulty adhering to walking exercise activity at the desired intensity (ie, not walking at a pace that elicits moderate‐to‐severe ischemic leg symptoms) at least 4 to 5 days per week. Individuals in either group who meet 1 or more of these criteria may receive additional unscheduled individual calls from the coach, as appropriate. For WL+EX the coach additionally contacts the participant between weekly scheduled interactions if dashboard data show 1 or more of the following: (1) absence of self‐monitoring for &gt;4 days, (2) overly rapid weight loss (&gt;1.36 kg [≈3 pounds]/wk for 3 consecutive weeks); (3) a 2‐week period without at least 0.23 kg [0.50 pounds] weight loss/wk (ie, 0.46 kg [1.0 pound] per 2 weeks) (this monitoring begins in week 3 of the intervention); or (4) nutritional concerns (ie, inadequate protein intake). If a participant randomized to WL+EX does not lose weight for a 3‐week period and they are adherent to dietary goals, the calorie goal is reduced.</p>
                </sec>
                <sec id="jah38753-sec-0015">
                  <title>Monitoring Intervention Fidelity</title>
                  <p>Group meetings and individual coaching calls are audio recorded and a 10% subsample of sessions is selected quarterly by the Data Coordinating Center for review. Investigators evaluate and rate assigned sessions using a fidelity checklist (Table <xref rid="jah38753-tbl-0005" ref-type="table">5</xref>). Coaches with a mean score of &lt;70% undergo additional training and recertification.</p>
                  <table-wrap position="float" id="jah38753-tbl-0005" content-type="Table">
                    <label>Table 5</label>
                    <caption>
                      <p>Outcomes of the PROVE Trial. For Each Outcome, We Hypothesize That Weight Loss Plus Exercise (WL+EX) Will Have Greater Improvement, Compared With Exercise (EX)</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <col align="left" span="1"/>
                      <col align="left" span="1"/>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Primary outcome</td>
                          <td align="left" rowspan="1" colspan="1">
                            <list list-type="simple" id="jah38753-list-0056">
                              <list-item id="jah38753-li-0084">
                                <label>‐</label>
                                <p>12‐mo change in 6‐min walk distance</p>
                              </list-item>
                            </list>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Secondary outcomes</td>
                          <td align="left" rowspan="1" colspan="1">
                            <list list-type="simple" id="jah38753-list-0057">
                              <list-item id="jah38753-li-0085">
                                <label>‐</label>
                                <p>Minutes of walking exercise/wk during the last month of the 12‐mo trial</p>
                              </list-item>
                              <list-item id="jah38753-li-0086">
                                <label>‐</label>
                                <p>12‐mo change in physical activity</p>
                              </list-item>
                              <list-item id="jah38753-li-0087">
                                <label>‐</label>
                                <p>12‐mo change in WIQ distance score</p>
                              </list-item>
                              <list-item id="jah38753-li-0088">
                                <label>‐</label>
                                <p>12‐mo change in PROMIS mobility questionnaire</p>
                              </list-item>
                            </list>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Tertiary outcomes</td>
                          <td align="left" rowspan="1" colspan="1">
                            <list list-type="simple" id="jah38753-list-0058">
                              <list-item id="jah38753-li-0089">
                                <label>‐</label>
                                <p>12‐mo change in perceived exertional effort at the end of the 6‐min walk test</p>
                              </list-item>
                              <list-item id="jah38753-li-0090">
                                <label>‐</label>
                                <p>12‐mo change in diet quality measured by change in Healthy Eating Index</p>
                              </list-item>
                            </list>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Exploratory outcomes</td>
                          <td align="left" rowspan="1" colspan="1">
                            <list list-type="simple" id="jah38753-list-0059">
                              <list-item id="jah38753-li-0091">
                                <label>‐</label>
                                <p>12‐mo change in the short physical performance battery</p>
                              </list-item>
                              <list-item id="jah38753-li-0092">
                                <label>‐</label>
                                <p>12‐mo change in the WIQ walking speed and the WIQ stair climbing scores</p>
                              </list-item>
                              <list-item id="jah38753-li-0093">
                                <label>‐</label>
                                <p>12‐mo change in calf muscle biopsy measured cytochrome C oxidase enzyme activity</p>
                              </list-item>
                              <list-item id="jah38753-li-0094">
                                <label>‐</label>
                                <p>12‐mo change in calf muscle biopsy measures of mitochondrial biogenesis (PGC‐1α), capillary density (capillaries per muscle fiber), and calf muscle inflammation (IL‐6, TNF‐α, and IL‐1β).</p>
                              </list-item>
                            </list>
                          </td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot id="jah38753-ntgp-0005">
                      <fn id="jah38753-note-0010">
                        <p>EX indicates exercise; IL, interleukin; PGC, peroxisome proliferator‐activated receptor‐gamma coactivator; PROMIS, Patient‐Reported Outcomes Measurement Information System; PROVE, Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss; TNF, tumor necrosis factor; WIQ, Walking Impairment Questionnaire; and WL+EX, weight loss plus exercise.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
              </sec>
              <sec id="jah38753-sec-0016">
                <title>Outcomes</title>
                <p>Outcomes are shown in Table <xref rid="jah38753-tbl-0005" ref-type="table">5</xref>. Outcome assessors are blinded to group assignment. Outcome assessors at each site are trained in data collection by the principal investigator's (MMM) staff and certified by the principal investigator or her designee, using a detailed checklist developed for the study protocol. Study coordinators undergo recertification approximately every 6 months. When deficiencies are identified, interviewers are retrained and reassessed.</p>
                <sec id="jah38753-sec-0017">
                  <title><styled-content style="fixed-case" toggle="no">6‐Minute</styled-content> Walk</title>
                  <p>In the 6‐minute walk, participants walk back and forth along a 100‐ft hallway for 6 minutes after standardized instructions are read from a script. The script instructs participants to complete as many laps as possible during the 6 minutes. The primary outcome is the total distance covered during the 6 minutes. The BORG scale of perceived exertion is administered at the end of the walk to evaluate perceived effort at baseline and follow‐up.</p>
                </sec>
                <sec id="jah38753-sec-0018">
                  <title>Questionnaires</title>
                  <p>Health‐related quality of life is assessed with the Patient‐Reported Outcomes Measurement Information System mobility questionnaire<xref rid="jah38753-bib-0020" ref-type="bibr"><sup>20</sup></xref> and the Walking Impairment Questionnaire.<xref rid="jah38753-bib-0021" ref-type="bibr"><sup>21</sup></xref> Leg symptoms are assessed with the San Diego Claudication Questionnaire.<xref rid="jah38753-bib-0022" ref-type="bibr"><sup>22</sup></xref> Frequency of exercise activity at baseline and follow‐up is collected via administered questionnaires.</p>
                </sec>
                <sec id="jah38753-sec-0019">
                  <title>Physical Activity</title>
                  <p>Physical activity during daily life is measured over 10 days at baseline and follow‐up, using the ActiGraph accelerometer. Up to 7 days of wear time will be used in analyses. Participants are instructed to put on the ActiGraph when they wake up and take it off when they go to sleep, removing it only for bathing.</p>
                </sec>
                <sec id="jah38753-sec-0020">
                  <title>Dietary Assessment</title>
                  <p>The standard semi‐quantitative food frequency questionnaire, the Diet History Questionnaire III,<xref rid="jah38753-bib-0023" ref-type="bibr"><sup>23</sup></xref> is used to estimate energy, macronutrient, and micronutrient intake at baseline and 12‐month follow‐up.</p>
                </sec>
                <sec id="jah38753-sec-0021">
                  <title>Short Physical Performance Battery</title>
                  <p>The short physical performance battery is a composite score (range 0–12, 12 = best) that includes assessment of 4‐meter walking velocity at usual pace, standing balance, and time required to stand 5 times from a seated position.<xref rid="jah38753-bib-0024" ref-type="bibr"><sup>24</sup></xref>, <xref rid="jah38753-bib-0025" ref-type="bibr"><sup>25</sup></xref> Each of the 3 short physical performance battery components is scored on a 0 to 4 scale. The 4‐m walking velocity is performed by asking the participant to walk ≈16 feet in a corridor at their usual pace, as if they are “walking down the street to go to the store.” The time required to walk the first 4 m is recorded. The measure is performed twice, and the faster time is used in analyses. Standing balance is measured by asking participants to hold 3 separate standing positions for 10 s each. The 3 standing positions are side‐by‐side stand, semi‐tandem stand, and the tandem stand. Time required to stand from a seated position 5 times as fast as possible is also measured.</p>
                </sec>
                <sec id="jah38753-sec-0022">
                  <title>Height, Weight, and Waist Circumference</title>
                  <p>Height and weight and waist circumference are measured at baseline using standard procedures. Weight and waist circumference are repeated at 6‐ and 12‐month follow‐up.</p>
                </sec>
                <sec id="jah38753-sec-0023">
                  <title>Muscle Biopsies</title>
                  <p>For an exploratory‐specific aim, 50 participants randomized at Northwestern undergo muscle biopsies. Gastrocnemius muscle biopsy measures consist of mitochondrial activity (cytochrome c oxidase activity), mitochondrial biogenesis (peroxisome proliferator‐activated receptor‐gamma coactivator enzyme activity), mitochondrial biogenesis (PGC‐1α), capillary density (capillaries per muscle fiber), calf muscle inflammation (interleukin‐6, tumor necrosis factor‐α, and interleukin‐1β), and abundance of senescent cells, compared with EX. These measures will help delineate biologic pathways that may mediate improved 6‐minute walk distance in response to WL+EX, compared with EX. Gastrocnemius muscle biopsies are obtained from an incision in the medial head of the gastrocnemius muscle in the leg with lower ABI, at ≈67% of the distance between the medial malleolus and the medial aspect of the proximal tibia.<xref rid="jah38753-bib-0026" ref-type="bibr"><sup>26</sup></xref> Biopsies are performed at baseline and 12 month follow‐up, with the 12‐month biopsy incision performed adjacent to the site of the baseline biopsy, denoted by the incision scar.</p>
                </sec>
                <sec id="jah38753-sec-0024">
                  <title>Statistical Considerations</title>
                  <p>Comparisons will be made by using contrasts at 12 months in a mixed‐model repeated measures analysis of covariance model with an unstructured covariance matrix to account for the fact that multiple measurements within a participant over time are not independent. We focus on the contrast at 12 months because our interest is on that time point. However, including all time points (ie, 6 and 12 months) will allow us to borrow strength across the time points when there may be missing data at 12 months. Predictor variables as fixed effects will include treatment (EX versus WL+EX), time (6 versus 12 months), and the baseline (prerandomization) value of the end point being analyzed. Field center and recruitment wave within center will be included as random effects. All participants will be asked to complete follow‐up testing, regardless of adherence to their intervention. Tests of hypotheses and reported <italic toggle="yes">P</italic> values will be 2‐sided using the intention‐to‐treat principle at the 5% level. We have 1 primary outcome, 5 secondary outcomes, and 7 exploratory outcomes. We do not plan an explicit adjustment for multiplicity for multiple outcomes. However, we will make explicit the number of outcomes explored. Subgroups of interest defined a priori include sex, race or ethnicity (Black versus non‐Black), baseline BMI (median split), baseline 6‐minutes walk performance (median split), baseline smoking status (current versus never and past), age (median split), presence/absence of diabetes, ABI &lt;0.6 versus ≥0.6, presence/absence of classical claudication symptoms, and presence/absence of exertional leg symptoms.</p>
                  <p>To account for correlation of baseline and follow‐up, we used data from GOALS<xref rid="jah38753-bib-0016" ref-type="bibr"><sup>16</sup></xref> to estimate residual SDs after adjustment for the baseline level of the response and correlations. For the primary outcome of the 6‐minute walk distance, the root mean squared error was 63.0 m. For the calculation of power, we used a 2‐sample <italic toggle="yes">t</italic> test and assumed a sample size of 212 participants, a 12‐month retention of at least 85% (a net sample size of at least 180), and 2‐sided tests at the 5% level. To account for the group‐based intervention delivery, we calculated the design effect, which is the ratio of variances comparing a simple randomized design to a cluster randomized design as 1+ICC[n−1], where n is the size of each group and ICC is the interclass correlation coefficient. The design effect is also the ratio of effective sample sizes for designs where the subjects are randomized independently compared with a group‐randomized design.<xref rid="jah38753-bib-0027" ref-type="bibr"><sup>27</sup></xref> In the GOALS study, we delivered the intervention in a group setting and we used data from that study to estimate the ICC within a group for 6‐minute walk at 12 months as 0.0297. We assumed a similar ICC for the PROVE Trial and an average cluster size of 7 (the most we expect) to get a design effect of 1+0.0297 [7−1] =1.178. Therefore, we have assumed an effective sample size of 212×0.85/1.178=152.9 to account for loss to follow‐up and clustering. Power for the primary outcome is 0.681 for a difference of at least 25 m in the 6‐minute walk test and goes up to 0.83 for 30 m, 0.925 for 35 m, and 0.973 for 40 m. Note that these power estimates are slightly conservative as we will borrow strength from the 6‐month visit in our mixed model. Meaningful change has been defined for change in 6‐minute walk performance: a 20‐ to 30‐m change in the 6‐minute walk represents a small meaningful change, and 50 m represents a large meaningful change.<xref rid="jah38753-bib-0028" ref-type="bibr"><sup>28</sup></xref>, <xref rid="jah38753-bib-0029" ref-type="bibr"><sup>29</sup></xref>, <xref rid="jah38753-bib-0030" ref-type="bibr"><sup>30</sup></xref> The GOALS Trial achieved a 53.5‐m difference in 6‐minute walk between the intervention and control groups.<xref rid="jah38753-bib-0016" ref-type="bibr"><sup>16</sup></xref> We believe that WL+EX will achieve at least 60% of the benefit of the home exercise alone, or 32.1 m. Our own (unpublished) pilot study demonstrated an improvement of 64.1 m (95% CI, 10.6–118) over 7 weeks. Therefore, we believe that WL+EX will improve 6‐minute walk distance by at least 30 m over EX.</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jah38753-sec-0025">
              <title>Discussion</title>
              <p>Among people with PAD who have overweight or obesity, the PROVE Trial will examine whether a diet and weight loss intervention combined with walking exercise results in significantly greater improvement in 6‐minute walk distance at 12‐month follow‐up, compared with walking exercise alone. There are at least 3 potential mechanisms by which weight loss could improve walking outcomes in people with overweight or obesity and PAD. First, in individuals with PAD with overweight/obesity, weight loss may improve walking performance by reducing the energy or perceived effort required during the 6‐minute walk. Second, weight loss in people with PAD with overweight/obesity may improve adherence to regular walking exercise, thereby facilitating greater response to a walking exercise intervention. Third, based on preclinical evidence, weight loss may improve the pathophysiologic changes that characterize PAD. Pathophysiologic changes may include improved lower extremity perfusion,<xref rid="jah38753-bib-0031" ref-type="bibr"><sup>31</sup></xref> improved skeletal muscle mitochondrial bioenergetics, and/or reduced inflammation, which may have direct adverse effects on muscle,<xref rid="jah38753-bib-0032" ref-type="bibr"><sup>32</sup></xref>, <xref rid="jah38753-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="jah38753-bib-0034" ref-type="bibr"><sup>34</sup></xref>, <xref rid="jah38753-bib-0035" ref-type="bibr"><sup>35</sup></xref> thereby improving walking performance. For example, in a rat model of PAD, obese rats, when compared with rats that were not obese, had hind limb arterial vasoconstriction and reduced vasodilation in response to nitric oxide.<xref rid="jah38753-bib-0031" ref-type="bibr"><sup>31</sup></xref>, <xref rid="jah38753-bib-0033" ref-type="bibr"><sup>33</sup></xref>
</p>
              <p>However, there are several potential reasons that weight loss may not improve walking performance in people with PAD with overweight/obesity. First, in older people, including people with PAD, weight loss has been associated with loss of skeletal muscle.<xref rid="jah38753-bib-0036" ref-type="bibr"><sup>36</sup></xref>, <xref rid="jah38753-bib-0037" ref-type="bibr"><sup>37</sup></xref>, <xref rid="jah38753-bib-0038" ref-type="bibr"><sup>38</sup></xref> In a longitudinal observational study of 389 people with PAD and mean BMI of 28.1 (SD, 5.1) at baseline, people who engaged in intentional weight loss had significantly greater decline in calf muscle area, measured by computed tomography scan, at 3.23 years (SD, 1.37) follow‐up, compared with those who did not engage in intentional weight loss.<xref rid="jah38753-bib-0036" ref-type="bibr"><sup>36</sup></xref> People with PAD already have reduced calf muscle area compared with those without PAD.<xref rid="jah38753-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38753-bib-0039" ref-type="bibr"><sup>39</sup></xref> Weight loss that exacerbates sarcopenia could be detrimental for people with PAD. Second, although recent literature<xref rid="jah38753-bib-0040" ref-type="bibr"><sup>40</sup></xref> indicates that attending to multiple health behaviors simultaneously can be beneficial and create a synergistic effect on positive health behavior, it is unclear whether these synergistic effects will also be observed in individuals with PAD. Third, while weight loss initially relies on dietary changes, physical activity is often necessary to realize weight loss maintenance, which may be challenging in this often physically inactive population.<xref rid="jah38753-bib-0041" ref-type="bibr"><sup>41</sup></xref> Fourth, the added burden of discomfort, pain, and heaviness that individuals with PAD with overweight or obesity may experience may make behavior change to attain weight loss more difficult compared with people without PAD who have overweight or obesity. For participants randomized to WL+EX, extreme difficulty making the behavior changes in diet or lack of perceived success could discourage progress or sustained engagement in the intervention.</p>
              <p>It is also possible that the technological component of the study interventions may be too burdensome for some participants. However, the app has been used successfully to support physical activity and weight loss in other studies, and weight loss has been achieved in prior clinical trials of people who are overweight and obese and who have metabolic syndrome.<xref rid="jah38753-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jah38753-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jah38753-bib-0019" ref-type="bibr"><sup>19</sup></xref>, <xref rid="jah38753-bib-0040" ref-type="bibr"><sup>40</sup></xref>, <xref rid="jah38753-bib-0042" ref-type="bibr"><sup>42</sup></xref>, <xref rid="jah38753-bib-0043" ref-type="bibr"><sup>43</sup></xref>, <xref rid="jah38753-bib-0044" ref-type="bibr"><sup>44</sup></xref> If the WL+EX group sufficiently improves physical functioning above that of EX alone, investigators will have established an additional intervention that could improve the lives of some individuals with PAD without undue burden of additional in‐person health care visits.</p>
            </sec>
            <sec sec-type="conclusions" id="jah38753-sec-0026">
              <title>Conclusions</title>
              <p>The PROVE Trial is a multicentered randomized clinical trial that will evaluate the effect of weight loss combined with home‐based walking exercise, compared with home‐based walking exercise alone on walking performance in individuals with PAD. If the proposed hypotheses are supported, the PROVE Trial will have important implications for the large and growing number of people with PAD who have overweight or obesity.</p>
            </sec>
            <sec id="jah38753-sec-0027">
              <title>Source of Funding</title>
              <p>This study is funded by National Heart Lung and Blood Institute, UH3HL141729 (PI McDermott) and U24HL141732 (PI Ambrosius) and supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health.</p>
            </sec>
            <sec id="jah38753-sec-0028">
              <title>Disclosures</title>
              <p>Dr. McDermott reported receiving research funding from Regeneron and Helixmith and other research support from ArtAssist, Chromadex, ReserveAge, Mars Company, and personal feeds from Cambrain biopharma. Dr. Spring reported receiving research funding from Actigraph scientific advisory board.</p>
            </sec>
          </body>
          <back>
            <ref-list content-type="cited-references" id="jah38753-bibl-0001">
              <title>References</title>
              <ref id="jah38753-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0001"><string-name><surname>Song</surname><given-names>P</given-names></string-name>, <string-name><surname>Rudan</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FJI</given-names></string-name>, <string-name><surname>Rahimi</surname><given-names>K</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FGR</given-names></string-name>, <string-name><surname>Rudan</surname><given-names>I</given-names></string-name>. <article-title>Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis</article-title>. <source>Lancet Glob Health</source>. <year>2019</year>;<volume>7</volume>:<fpage>e1020</fpage>–<lpage>e1030</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s2214-109X(19)30255-4</pub-id>
<pub-id pub-id-type="pmid">31303293</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0002"><string-name><surname>Polonsky</surname><given-names>TS</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>. <article-title>Lower extremity peripheral artery disease without chronic limb‐threatening ischemia: a review</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>325</volume>:<fpage>2188</fpage>–<lpage>2198</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2021.2126</pub-id>
<pub-id pub-id-type="pmid">34061140</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0003"><string-name><surname>Gerhard‐Herman</surname><given-names>MD</given-names></string-name>, <string-name><surname>Gornik</surname><given-names>HL</given-names></string-name>, <string-name><surname>Barrett</surname><given-names>C</given-names></string-name>, <string-name><surname>Barshes</surname><given-names>NR</given-names></string-name>, <string-name><surname>Corriere</surname><given-names>MA</given-names></string-name>, <string-name><surname>Drachman</surname><given-names>DE</given-names></string-name>, <string-name><surname>Fleisher</surname><given-names>LA</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FGR</given-names></string-name>, <string-name><surname>Hamburg</surname><given-names>NM</given-names></string-name>, <string-name><surname>Kinlay</surname><given-names>S</given-names></string-name>, et al. <article-title>2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines</article-title>. <source>Circulation</source>. <year>2017</year>;<volume>135</volume>:<fpage>e726</fpage>–<lpage>e779</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000000471</pub-id>
<pub-id pub-id-type="pmid">27840333</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0004"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Greenland</surname><given-names>P</given-names></string-name>, <string-name><surname>Tan</surname><given-names>J</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>JR</given-names></string-name>, <string-name><surname>Clark</surname><given-names>E</given-names></string-name>, et al. <article-title>Obesity, weight change, and functional decline in peripheral arterial disease</article-title>. <source>J Vasc Surg</source>. <year>2006</year>;<volume>43</volume>:<fpage>1198</fpage>–<lpage>1204</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2006.02.036</pub-id>
<pub-id pub-id-type="pmid">16765239</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0005"><string-name><surname>Golledge</surname><given-names>J</given-names></string-name>, <string-name><surname>Leicht</surname><given-names>A</given-names></string-name>, <string-name><surname>Crowther</surname><given-names>RG</given-names></string-name>, <string-name><surname>Clancy</surname><given-names>P</given-names></string-name>, <string-name><surname>Spinks</surname><given-names>WL</given-names></string-name>, <string-name><surname>Quigley</surname><given-names>F</given-names></string-name>. <article-title>Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication</article-title>. <source>J Vasc Surg</source>. <year>2007</year>;<volume>45</volume>:<fpage>40</fpage>–<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2006.09.006</pub-id>
<pub-id pub-id-type="pmid">17123770</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0006"><string-name><surname>Raval</surname><given-names>Z</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Liao</surname><given-names>Y</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>. <article-title>Higher body mass index is associated with more adverse changes in calf muscle characteristics in peripheral arterial disease</article-title>. <source>J Vasc Surg</source>. <year>2012</year>;<volume>55</volume>:<fpage>1015</fpage>–<lpage>1024</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvs.2011.10.105</pub-id>
<pub-id pub-id-type="pmid">22365177</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0007"><collab collab-type="authors">GBD 2015 Obesity Collaborators</collab>
, <string-name><surname>Afshin</surname><given-names>A</given-names></string-name>, <string-name><surname>Forouzanfar</surname><given-names>MH</given-names></string-name>, <string-name><surname>Reitsma</surname><given-names>MB</given-names></string-name>, <string-name><surname>Sur</surname><given-names>P</given-names></string-name>, <string-name><surname>Estep</surname><given-names>K</given-names></string-name>, <string-name><surname>Lee</surname><given-names>A</given-names></string-name>, <string-name><surname>Marczak</surname><given-names>L</given-names></string-name>, <string-name><surname>Mokdad</surname><given-names>AH</given-names></string-name>, <string-name><surname>Moradi‐Lakeh</surname><given-names>M</given-names></string-name>, et al. <article-title>Health effects of overweight and obesity in 195 countries over 25 years</article-title>. <source>N Engl J Med</source>. <year>2017</year>;<volume>377</volume>:<fpage>13</fpage>–<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1614362</pub-id>
<pub-id pub-id-type="pmid">28604169</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0008"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Leeuwenburgh</surname><given-names>C</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Sufit</surname><given-names>R</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>L</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>MR</given-names></string-name>, <string-name><surname>Stein</surname><given-names>JH</given-names></string-name>, <string-name><surname>Lloyd‐Jones</surname><given-names>D</given-names></string-name>, et al. <article-title>Effect of resveratrol on walking performance in older people with peripheral artery disease: the RESTORE randomized clinical trial</article-title>. <source>JAMA Cardiol</source>. <year>2017</year>;<volume>2</volume>:<fpage>902</fpage>–<lpage>907</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamacardio.2017.0538</pub-id>
<pub-id pub-id-type="pmid">28403379</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0009"><string-name><surname>Naqvi</surname><given-names>AZ</given-names></string-name>, <string-name><surname>Davis</surname><given-names>RB</given-names></string-name>, <string-name><surname>Mukamal</surname><given-names>KJ</given-names></string-name>. <article-title>Nutrient intake and peripheral artery disease in adults: key considerations in cross‐sectional studies</article-title>. <source>Clin Nutr</source>. <year>2014</year>;<volume>33</volume>:<fpage>443</fpage>–<lpage>447</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2013.06.011</pub-id>
<pub-id pub-id-type="pmid">23920500</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0010"><string-name><surname>Wieczór</surname><given-names>R</given-names></string-name>, <string-name><surname>Wieczór</surname><given-names>AM</given-names></string-name>, <string-name><surname>Gadomska</surname><given-names>G</given-names></string-name>, <string-name><surname>Stankowska</surname><given-names>K</given-names></string-name>, <string-name><surname>Fabisiak</surname><given-names>J</given-names></string-name>, <string-name><surname>Suppan</surname><given-names>K</given-names></string-name>, <string-name><surname>Pulkowski</surname><given-names>G</given-names></string-name>, <string-name><surname>Budzyński</surname><given-names>J</given-names></string-name>, <string-name><surname>Rość</surname><given-names>D</given-names></string-name>. <article-title>Overweight and obesity versus concentrations of VEGF‐A, sVEGFR‐1, and sVEGFR‐2 in plasma of patients with lower limb chronic ischemia</article-title>. <source>J Zhejiang Univ Sci B</source>. <year>2016</year>;<volume>17</volume>:<fpage>842</fpage>–<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1631/jzus.B1600009</pub-id>
<pub-id pub-id-type="pmid">27819131</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0011"><string-name><surname>Wells</surname><given-names>GD</given-names></string-name>, <string-name><surname>Noseworthy</surname><given-names>MD</given-names></string-name>, <string-name><surname>Hamilton</surname><given-names>J</given-names></string-name>, <string-name><surname>Tarnopolski</surname><given-names>M</given-names></string-name>, <string-name><surname>Tein</surname><given-names>I</given-names></string-name>. <article-title>Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome</article-title>. <source>Can J Neurol Sci</source>. <year>2008</year>;<volume>35</volume>:<fpage>31</fpage>–<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1017/s0317167100007538</pub-id>
<pub-id pub-id-type="pmid">18380275</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0012"><string-name><surname>Waters</surname><given-names>DL</given-names></string-name>, <string-name><surname>Ward</surname><given-names>AL</given-names></string-name>, <string-name><surname>Villareal</surname><given-names>DT</given-names></string-name>. <article-title>Weight loss in obese adults 65 years and older: a review of the controversy</article-title>. <source>Exp Gerontol</source>. <year>2013</year>;<volume>48</volume>:<fpage>1054</fpage>–<lpage>1061</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2013.02.005</pub-id>
<pub-id pub-id-type="pmid">23403042</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0013"><string-name><surname>Amirhamzeh</surname><given-names>MM</given-names></string-name>, <string-name><surname>Chant</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Rees</surname><given-names>JL</given-names></string-name>, <string-name><surname>Hands</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Powell</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>WB</given-names></string-name>. <article-title>A comparative study of treadmill tests and heel raising exercise for peripheral arterial disease</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>1997</year>;<volume>13</volume>:<fpage>301</fpage>–<lpage>305</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1078-5884(97)80102-5</pub-id>
<pub-id pub-id-type="pmid">9129604</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0014"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Domanchuk</surname><given-names>K</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>M</given-names></string-name>, <string-name><surname>Jones</surname><given-names>DL</given-names></string-name>, <string-name><surname>Pearce</surname><given-names>WH</given-names></string-name>, et al. <article-title>The Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease</article-title>. <source>Contemp Clin Trials</source>. <year>2012</year>;<volume>33</volume>:<fpage>1311</fpage>–<lpage>1320</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cct.2012.08.001</pub-id>
<pub-id pub-id-type="pmid">23158112</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0015"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Treat‐Jacobson</surname><given-names>D</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Lloyd‐Jones</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>L</given-names></string-name>, <string-name><surname>Polonsky</surname><given-names>T</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>MR</given-names></string-name>, <string-name><surname>Bazzano</surname><given-names>L</given-names></string-name>, et al. <article-title>Effect of low‐intensity vs high‐intensity home‐based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>325</volume>:<fpage>1266</fpage>–<lpage>1276</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2021.2536</pub-id>
<pub-id pub-id-type="pmid">33821898</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0016"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>. <article-title>Home‐based walking exercise interevention in peripheral artery disease</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>310</volume>:<fpage>57</fpage>–<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2013.7231</pub-id>
<pub-id pub-id-type="pmid">23821089</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0017"><string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Duncan</surname><given-names>JM</given-names></string-name>, <string-name><surname>Janke</surname><given-names>EA</given-names></string-name>, <string-name><surname>Andrea</surname><given-names>T</given-names></string-name>, <string-name><surname>McFadden</surname><given-names>HG</given-names></string-name>, <string-name><surname>DeMott</surname><given-names>A</given-names></string-name>, <string-name><surname>Pictor</surname><given-names>A</given-names></string-name>, <string-name><surname>Epstein</surname><given-names>LH</given-names></string-name>, <string-name><surname>Siddique</surname><given-names>J</given-names></string-name>, <string-name><surname>Pellegrini</surname><given-names>CA</given-names></string-name>, et al. <article-title>Integrating technology into standard weight loss treatment: a randomized controlled trial</article-title>. <source>JAMA Intern Med</source>. <year>2013</year>;<volume>173</volume>:<fpage>105</fpage>–<lpage>111</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamainternmed.2013.1221</pub-id>
<pub-id pub-id-type="pmid">23229890</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0018"><string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Pellegrini</surname><given-names>CA</given-names></string-name>, <string-name><surname>Pfammatter</surname><given-names>A</given-names></string-name>, <string-name><surname>Duncan</surname><given-names>JM</given-names></string-name>, <string-name><surname>Pictor</surname><given-names>A</given-names></string-name>, <string-name><surname>McFadden</surname><given-names>HG</given-names></string-name>, <string-name><surname>Siddique</surname><given-names>J</given-names></string-name>, <string-name><surname>Hedeker</surname><given-names>D</given-names></string-name>. <article-title>Effects of an abbreviated obesity intervention supported by mobile technology: the ENGAGED randomized clinical trial</article-title>. <source>Obesity</source>. <year>2017</year>;<volume>25</volume>:<fpage>1191</fpage>–<lpage>1198</lpage>. doi: <pub-id pub-id-type="doi">10.1002/oby.21842</pub-id>
<pub-id pub-id-type="pmid">28494136</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0019"><string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Pfammatter</surname><given-names>AF</given-names></string-name>, <string-name><surname>Marchese</surname><given-names>SH</given-names></string-name>, <string-name><surname>Stump</surname><given-names>T</given-names></string-name>, <string-name><surname>Pellegrini</surname><given-names>C</given-names></string-name>, <string-name><surname>McFadden</surname><given-names>HG</given-names></string-name>, <string-name><surname>Hedeker</surname><given-names>D</given-names></string-name>, <string-name><surname>Siddique</surname><given-names>J</given-names></string-name>, <string-name><surname>Jordan</surname><given-names>N</given-names></string-name>, <string-name><surname>Collins</surname><given-names>LM</given-names></string-name>. <article-title>A factorial experiment to optimize remotely delivered behavioral treatment for obesity: results of the Opt‐IN study</article-title>. <source>Obesity (Silver Spring)</source>. <year>2020</year>;<volume>28</volume>:<fpage>1652</fpage>–<lpage>1662</lpage>. doi: <pub-id pub-id-type="doi">10.1002/oby.22915</pub-id>
<pub-id pub-id-type="pmid">32656994</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0020"><string-name><surname>Hays</surname><given-names>RD</given-names></string-name>, <string-name><surname>Spritzer</surname><given-names>KL</given-names></string-name>, <string-name><surname>Amtmann</surname><given-names>D</given-names></string-name>, <string-name><surname>Lai</surname><given-names>JS</given-names></string-name>, <string-name><surname>Dewitt</surname><given-names>EM</given-names></string-name>, <string-name><surname>Rothrock</surname><given-names>N</given-names></string-name>, <string-name><surname>Dewalt</surname><given-names>DA</given-names></string-name>, <string-name><surname>Riley</surname><given-names>WT</given-names></string-name>, <string-name><surname>Fries</surname><given-names>JF</given-names></string-name>, <string-name><surname>Krishnan</surname><given-names>E</given-names></string-name>. <article-title>Upper‐extremity and mobility subdomains from the Patient‐Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2013</year>;<volume>94</volume>:<fpage>2291</fpage>–<lpage>2296</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.apmr.2013.05.014</pub-id>
<pub-id pub-id-type="pmid">23751290</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0021"><string-name><surname>Regensteiner</surname><given-names>JG</given-names></string-name>, <string-name><surname>Steiner</surname><given-names>J</given-names></string-name>, <string-name><surname>Panzer</surname><given-names>R</given-names></string-name>, <string-name><surname>Hiatt</surname><given-names>WR</given-names></string-name>. <article-title>Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease</article-title>. <source>J Vasc Med Biol</source>. <year>1990</year>;<volume>2</volume>:<fpage>142</fpage>–<lpage>152</lpage>.</mixed-citation>
              </ref>
              <ref id="jah38753-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0022"><string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Denenberg</surname><given-names>JO</given-names></string-name>, <string-name><surname>Bird</surname><given-names>CE</given-names></string-name>, <string-name><surname>Fronek</surname><given-names>A</given-names></string-name>, <string-name><surname>Klauber</surname><given-names>MR</given-names></string-name>, <string-name><surname>Langer</surname><given-names>RD</given-names></string-name>. <article-title>The correlation between symptoms and non‐invasive test results in patients referred for peripheral arterial disease testing</article-title>. <source>Vasc Med</source>. <year>1996</year>;<volume>1</volume>:<fpage>65</fpage>–<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1358863X9600100112</pub-id>
<pub-id pub-id-type="pmid">9546918</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0023"><string-name><surname>Thompson</surname><given-names>FE</given-names></string-name>, <string-name><surname>Subar</surname><given-names>AF</given-names></string-name>, <string-name><surname>Brown</surname><given-names>CC</given-names></string-name>, <string-name><surname>Smith</surname><given-names>AF</given-names></string-name>, <string-name><surname>Sharbaugh</surname><given-names>CO</given-names></string-name>, <string-name><surname>Jobe</surname><given-names>JB</given-names></string-name>, <string-name><surname>Mittl</surname><given-names>B</given-names></string-name>, <string-name><surname>Gibson</surname><given-names>JT</given-names></string-name>, <string-name><surname>Ziegler</surname><given-names>RG</given-names></string-name>. <article-title>Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study</article-title>. <source>J Am Diet Assoc</source>. <year>2002</year>;<volume>102</volume>:<fpage>212</fpage>–<lpage>225</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0002-8223(02)90050-7</pub-id>
<pub-id pub-id-type="pmid">11846115</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0024"><string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Simonsick</surname><given-names>EM</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Glynn</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Berkman</surname><given-names>LF</given-names></string-name>, <string-name><surname>Blazer</surname><given-names>DG</given-names></string-name>, <string-name><surname>Scherr</surname><given-names>PA</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>RB</given-names></string-name>. <article-title>A short physical performance battery assessing lower extremity function: association with self‐reported disability and prediction of mortality and nursing home admission</article-title>. <source>J Gerontol</source>. <year>1994</year>;<volume>49</volume>:<fpage>M85</fpage>–<lpage>M94</lpage>. doi: <pub-id pub-id-type="doi">10.1093/geronj/49.2.M85</pub-id>
<pub-id pub-id-type="pmid">8126356</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0025"><string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Simonsick</surname><given-names>EM</given-names></string-name>, <string-name><surname>Salive</surname><given-names>ME</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>RB</given-names></string-name>. <article-title>Lower‐extremity function in persons over the age of 70 years as a predictor of subsequent disability</article-title>. <source>N Engl J Med</source>. <year>1995</year>;<volume>332</volume>:<fpage>556</fpage>–<lpage>561</lpage>. doi: <pub-id pub-id-type="doi">10.1056/nejm199503023320902</pub-id>
<pub-id pub-id-type="pmid">7838189</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0026"><string-name><surname>Mitsiopoulos</surname><given-names>N</given-names></string-name>, <string-name><surname>Baumgartner</surname><given-names>RN</given-names></string-name>, <string-name><surname>Heymsfield</surname><given-names>SB</given-names></string-name>, <string-name><surname>Lyons</surname><given-names>W</given-names></string-name>, <string-name><surname>Gallagher</surname><given-names>D</given-names></string-name>, <string-name><surname>Ross</surname><given-names>R</given-names></string-name>. <article-title>Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography</article-title>. <source>J Appl Physiol (1985)</source>. <year>1998</year>;<volume>85</volume>:<fpage>115</fpage>–<lpage>122</lpage>. doi: <pub-id pub-id-type="doi">10.1152/jappl.1998.85.1.115</pub-id>
<pub-id pub-id-type="pmid">9655763</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0027"><string-name><surname>Donner</surname><given-names>A</given-names></string-name>, <string-name><surname>Birkett</surname><given-names>N</given-names></string-name>, <string-name><surname>Buck</surname><given-names>C</given-names></string-name>. <article-title>Randomization by cluster. Sample size requirements and analysis</article-title>. <source>Am J Epidemiol</source>. <year>1981</year>;<volume>114</volume>:<fpage>906</fpage>–<lpage>914</lpage>. doi: <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a113261</pub-id>
<pub-id pub-id-type="pmid">7315838</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0028"><string-name><surname>Perera</surname><given-names>S</given-names></string-name>, <string-name><surname>Mody</surname><given-names>SH</given-names></string-name>, <string-name><surname>Woodman</surname><given-names>RC</given-names></string-name>, <string-name><surname>Studenski</surname><given-names>SA</given-names></string-name>. <article-title>Meaningful change and responsiveness in common physical performance measures in older adults</article-title>. <source>J Am Geriatr Soc</source>. <year>2006</year>;<volume>54</volume>:<fpage>743</fpage>–<lpage>749</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2006.00701.x</pub-id>
<pub-id pub-id-type="pmid">16696738</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0029"><string-name><surname>Holland</surname><given-names>AE</given-names></string-name>, <string-name><surname>Hill</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Conron</surname><given-names>M</given-names></string-name>, <string-name><surname>Munro</surname><given-names>P</given-names></string-name>, <string-name><surname>McDonald</surname><given-names>CF</given-names></string-name>. <article-title>Small changes in six‐minute walk distance are important in diffuse parenchymal lung disease</article-title>. <source>Respir Med</source>. <year>2009</year>;<volume>103</volume>:<fpage>1430</fpage>–<lpage>1435</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.rmed.2009.04.024</pub-id>
<pub-id pub-id-type="pmid">19477109</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0030"><string-name><surname>Puhan</surname><given-names>MA</given-names></string-name>, <string-name><surname>Mador</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Held</surname><given-names>U</given-names></string-name>, <string-name><surname>Goldstein</surname><given-names>R</given-names></string-name>, <string-name><surname>Guyatt</surname><given-names>GH</given-names></string-name>, <string-name><surname>Schunemann</surname><given-names>HJ</given-names></string-name>. <article-title>Interpretation of treatment changes in 6‐minute walk distance in patients with COPD</article-title>. <source>Eur Respir J</source>. <year>2008</year>;<volume>32</volume>:<fpage>637</fpage>–<lpage>643</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00140507</pub-id>
<pub-id pub-id-type="pmid">18550610</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0031"><string-name><surname>Frisbee</surname><given-names>JC</given-names></string-name>, <string-name><surname>Delp</surname><given-names>MD</given-names></string-name>. <article-title>Vascular function in the metabolic syndrome and the effects on skeletal muscle perfusion: lessons from the obese Zucker rat</article-title>. <source>Essays Biochem</source>. <year>2006</year>;<volume>42</volume>:<fpage>145</fpage>–<lpage>161</lpage>. doi: <pub-id pub-id-type="doi">10.1042/bse0420145</pub-id>
<pub-id pub-id-type="pmid">17144886</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0032"><string-name><surname>Marzetti</surname><given-names>E</given-names></string-name>, <string-name><surname>Wohlgemuth</surname><given-names>SE</given-names></string-name>, <string-name><surname>Anton</surname><given-names>SD</given-names></string-name>, <string-name><surname>Bernabei</surname><given-names>R</given-names></string-name>, <string-name><surname>Carter</surname><given-names>CS</given-names></string-name>, <string-name><surname>Leeuwenburgh</surname><given-names>C</given-names></string-name>. <article-title>Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives</article-title>. <source>Clin Geriatr Med</source>. <year>2009</year>;<volume>25</volume>:<fpage>715</fpage>–<lpage>732, ix</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cger.2009.07.002</pub-id>
<pub-id pub-id-type="pmid">19944269</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0033"><string-name><surname>Frisbee</surname><given-names>JC</given-names></string-name>, <string-name><surname>Stepp</surname><given-names>DW</given-names></string-name>. <article-title>Impaired NO‐dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2001</year>;<volume>281</volume>:<fpage>H1304</fpage>–<lpage>H1311</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpheart.2001.281.3.H1304</pub-id>
<pub-id pub-id-type="pmid">11514301</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0034"><string-name><surname>Upadhya</surname><given-names>B</given-names></string-name>, <string-name><surname>Haykowsky</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Eggebeen</surname><given-names>J</given-names></string-name>, <string-name><surname>Kitzman</surname><given-names>DW</given-names></string-name>. <article-title>Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction</article-title>. <source>Curr Heart Fail Rep</source>. <year>2015</year>;<volume>12</volume>:<fpage>205</fpage>–<lpage>214</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11897-015-0257-5</pub-id>
<pub-id pub-id-type="pmid">25750186</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0035"><string-name><surname>Sparks</surname><given-names>LM</given-names></string-name>, <string-name><surname>Xie</surname><given-names>H</given-names></string-name>, <string-name><surname>Koza</surname><given-names>RA</given-names></string-name>, <string-name><surname>Mynatt</surname><given-names>R</given-names></string-name>, <string-name><surname>Hulver</surname><given-names>MW</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Smith</surname><given-names>SR</given-names></string-name>. <article-title>A high‐fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle</article-title>. <source>Diabetes</source>. <year>2005</year>;<volume>54</volume>:<fpage>1926</fpage>–<lpage>1933</lpage>. doi: <pub-id pub-id-type="doi">10.2337/diabetes.54.7.1926</pub-id>
<pub-id pub-id-type="pmid">15983191</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0036"><string-name><surname>Polonsky</surname><given-names>TS</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D</given-names></string-name>, <string-name><surname>Bazzano</surname><given-names>LA</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>MR</given-names></string-name>, <string-name><surname>Leeuwenburgh</surname><given-names>C</given-names></string-name>, <string-name><surname>Sufit</surname><given-names>RL</given-names></string-name>, et al. <article-title>Associations of weight change with changes in calf muscle characteristics and functional decline in peripheral artery disease</article-title>. <source>J Am Heart Assoc</source>. <year>2019</year>;<volume>8</volume>:<elocation-id>e010890</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.118.010890</pub-id><pub-id pub-id-type="pmid">31257970</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0037"><string-name><surname>Villareal</surname><given-names>DT</given-names></string-name>, <string-name><surname>Chode</surname><given-names>S</given-names></string-name>, <string-name><surname>Parimi</surname><given-names>N</given-names></string-name>, <string-name><surname>Sinacore</surname><given-names>DR</given-names></string-name>, <string-name><surname>Hilton</surname><given-names>T</given-names></string-name>, <string-name><surname>Armamento‐Villareal</surname><given-names>R</given-names></string-name>, <string-name><surname>Napoli</surname><given-names>N</given-names></string-name>, <string-name><surname>Qualls</surname><given-names>C</given-names></string-name>, <string-name><surname>Shah</surname><given-names>K</given-names></string-name>. <article-title>Weight loss, exercise, or both and physical function in obese older adults</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>:<fpage>1218</fpage>–<lpage>1229</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1008234</pub-id>
<pub-id pub-id-type="pmid">21449785</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0038"><string-name><surname>Beavers</surname><given-names>KM</given-names></string-name>, <string-name><surname>Ambrosius</surname><given-names>WT</given-names></string-name>, <string-name><surname>Rejeski</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Burdette</surname><given-names>JH</given-names></string-name>, <string-name><surname>Walkup</surname><given-names>MP</given-names></string-name>, <string-name><surname>Sheedy</surname><given-names>JL</given-names></string-name>, <string-name><surname>Nesbit</surname><given-names>BA</given-names></string-name>, <string-name><surname>Gaukstern</surname><given-names>JE</given-names></string-name>, <string-name><surname>Nicklas</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Marsh</surname><given-names>AP</given-names></string-name>. <article-title>Effect of exercise type during intentional weight loss on body composition in older adults with obesity</article-title>. <source>Obesity (Silver Spring)</source>. <year>2017</year>;<volume>25</volume>:<fpage>1823</fpage>–<lpage>1829</lpage>. doi: <pub-id pub-id-type="doi">10.1002/oby.21977</pub-id>
<pub-id pub-id-type="pmid">29086504</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0039"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Hoff</surname><given-names>F</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Pearce</surname><given-names>WH</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Tian</surname><given-names>L</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>JR</given-names></string-name>, <string-name><surname>Sharma</surname><given-names>L</given-names></string-name>, <string-name><surname>Tan</surname><given-names>J</given-names></string-name>, et al. <article-title>Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease</article-title>. <source>J Am Geriatr Soc</source>. <year>2007</year>;<volume>55</volume>:<fpage>400</fpage>–<lpage>406</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2007.01092.x</pub-id>
<pub-id pub-id-type="pmid">17341243</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0040"><string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Pellegrini</surname><given-names>C</given-names></string-name>, <string-name><surname>McFadden</surname><given-names>HG</given-names></string-name>, <string-name><surname>Pfammatter</surname><given-names>AF</given-names></string-name>, <string-name><surname>Stump</surname><given-names>TK</given-names></string-name>, <string-name><surname>Siddique</surname><given-names>J</given-names></string-name>, <string-name><surname>King</surname><given-names>AC</given-names></string-name>, <string-name><surname>Hedeker</surname><given-names>D</given-names></string-name>. <article-title>Multicomponent mHealth intervention for large, sustained change in multiple diet and activity risk behaviors: the Make Better Choices 2 randomized controlled trial</article-title>. <source>J Med Internet Res</source>. <year>2018</year>;<volume>20</volume>:<elocation-id>e10528</elocation-id>. doi: <pub-id pub-id-type="doi">10.2196/10528</pub-id><pub-id pub-id-type="pmid">29921561</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0041"><string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <string-name><surname>Greenland</surname><given-names>P</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>, <string-name><surname>Celic</surname><given-names>L</given-names></string-name>, <string-name><surname>Criqui</surname><given-names>MH</given-names></string-name>, <string-name><surname>Chan</surname><given-names>C</given-names></string-name>, <string-name><surname>Martin</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>J</given-names></string-name>, <string-name><surname>Pearce</surname><given-names>WH</given-names></string-name>, et al. <article-title>The ankle brachial index is associated with leg function and physical activity: the walking and leg circulation study</article-title>. <source>Ann Intern Med</source>. <year>2002</year>;<volume>136</volume>:<fpage>873</fpage>–<lpage>883</lpage>. doi: <pub-id pub-id-type="doi">10.7326/0003-4819-136-12-200206180-00008</pub-id>
<pub-id pub-id-type="pmid">12069561</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0042"><string-name><surname>Spring</surname><given-names>B</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>K</given-names></string-name>, <string-name><surname>McFadden</surname><given-names>HG</given-names></string-name>, <string-name><surname>Vaughn</surname><given-names>J</given-names></string-name>, <string-name><surname>Kozak</surname><given-names>AT</given-names></string-name>, <string-name><surname>Smith</surname><given-names>M</given-names></string-name>, <string-name><surname>Moller</surname><given-names>AC</given-names></string-name>, <string-name><surname>Epstein</surname><given-names>LH</given-names></string-name>, <string-name><surname>Demott</surname><given-names>A</given-names></string-name>, <string-name><surname>Hedeker</surname><given-names>D</given-names></string-name>, et al. <article-title>Multiple behavior changes in diet and activity: a randomized controlled trial using mobile technology</article-title>. <source>Arch Intern Med</source>. <year>2012</year>;<volume>172</volume>:<fpage>789</fpage>–<lpage>796</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinternmed.2012.1044</pub-id>
<pub-id pub-id-type="pmid">22636824</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0043"><string-name><surname>Rejeski</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Ambrosius</surname><given-names>WT</given-names></string-name>, <string-name><surname>Burdette</surname><given-names>JH</given-names></string-name>, <string-name><surname>Walkup</surname><given-names>MP</given-names></string-name>, <string-name><surname>Marsh</surname><given-names>AP</given-names></string-name>. <article-title>Community weight loss to combat obesity and disability in at‐risk older adults</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2017</year>;<volume>72</volume>:<fpage>1547</fpage>–<lpage>1553</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/glw252</pub-id>
<pub-id pub-id-type="pmid">28064148</pub-id></mixed-citation>
              </ref>
              <ref id="jah38753-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jah38753-cit-0044"><string-name><surname>Rejeski</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Brubaker</surname><given-names>PH</given-names></string-name>, <string-name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Bearon</surname><given-names>LB</given-names></string-name>, <string-name><surname>McClelland</surname><given-names>JW</given-names></string-name>, <string-name><surname>Perri</surname><given-names>MG</given-names></string-name>, <string-name><surname>Ambrosius</surname><given-names>WT</given-names></string-name>. <article-title>Translating weight loss and physical activity programs into the community to preserve mobility in older, obese adults in poor cardiovascular health</article-title>. <source>Arch Intern Med</source>. <year>2011</year>;<volume>171</volume>:<fpage>880</fpage>–<lpage>886</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinternmed.2010.522</pub-id>
<pub-id pub-id-type="pmid">21263080</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
